School of Medicine
Showing 21-30 of 85 Results
-
Nancy A. Haug
Adjunct Clinical Professor, Psychiatry and Behavioral Sciences
BioNancy A. Haug, PhD is Adjunct Clinical Professor and Addiction Medicine fellowship program faculty in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She currently leads didactics and a journal club for Addiction Medicine fellows, and teaches a postdoctoral seminar on ethics and legal issues for the Clinical Psychology Fellowship Program. Dr. Haug's primary academic affiliation is Professor of Psychology at Palo Alto University, where she teaches, advises and supervises doctoral students in the PAU-Stanford PsyD Consortium. Dr. Haug previously served as faculty and attending psychologist in the Department of Psychiatry at the University of California San Francisco, and taught in the University of California, Berkeley Alcohol & Drug Studies program. She obtained her PhD in Clinical Psychology and Behavioral Medicine at the University of Maryland, Baltimore County and a Master's degree in Counseling Psychology at Loyola University, Maryland. She completed a clinical internship and postdoctoral fellowship at University of California, San Francisco and San Francisco General Hospital in public service and minority mental health.
Dr. Haug chairs the American Psychological Association (APA) Ethics Committee and formerly served on the California Psychological Association Ethics Committee. She is a Fellow, Member-at-Large for Practice, and President- Elect of the Society of Addiction Psychology (Division 50). Dr. Haug is on the editorial board of the Journal of Psychoactive Drugs and the Journal of Addictive Diseases. She was funded by SAMHSA for a practitioner-education initiative to expand training for evidence-based addiction treatment. Dr. Haug leads the Harm Reduction and Addiction Treatment Laboratory at PAU with current research studies on the implementation of evidence-based practices in addiction treatment, harm reduction for substance use, cannabis vaping and psychedelic-assisted psychotherapy.
Dr. Haug has been licensed as a psychologist in California since 2004, is board certified in addiction psychology by American Board of Professional Psychology, and has an independent practice in Los Gatos, CA. She has clinical expertise in treating substance misuse and eating disorders using motivational interviewing, cognitive-behavioral and mindfulness-based therapies including Acceptance and Commitment Therapy. Dr. Haug is a Stanford WellConnect referral for fellows, residents and faculty in her clinical practice. She completed the Stanford YogaX 200-Hour Yoga Teacher Training Program with healthcare setting emphasis. -
John Lyon Havlik
Postdoctoral Medical Fellow, Psychiatry
Resident in Psychiatry and Behavioral SciencesBioHello! I'm the inaugural Humanities and Social Medicine research track resident at Stanford University.
Psychiatric and substance use disorders are usually caught only after substantial, sometimes irreparable, harm has already occurred. My work is about changing that: I build artificial intelligence models that identify people earlier, and I evaluate whether the systems that receive them, like health plans, treatment facilities, and now generative AI chatbots, are equipped to respond appropriately. I believe this kind of early intervention will one day be commonplace and prevent a great deal of human suffering.
On the building side, I'm technical lead and first author on a supervised model that detects substance use disorders from EHR-like data, currently in press at Nature Mental Health; related work uses multimodal data to flag who will go on to develop opioid use disorder and to predict imminent psychiatric emergency-department visits. I also co-authored a Nature Medicine paper on how to rigorously test the true capabilities of medical AI. I work across a wide range of deterministic and probabilistic methods, including the transformer architectures behind modern "chatbots." My work has been featured in 40+ peer-reviewed publications and featured in national news outlets.
In production, spinout AI-enabled clinical workflow automation software I developed is in use at the U.S. Department of Veterans Affairs and here at Stanford. The aim of my work is to move advances in artificial intelligence out of publications and into the clinic.
On the evaluating side, I serve as an expert reviewer of AI-in-medicine trials for the State of Utah's Office of Artificial Intelligence Policy, and I am a sought-after health-tech advisor for Silicon Valley's leading venture capital firms and companies. I write on psychiatric services and health policy, recently in JAMA Health Forum on private-equity residential treatment and JAMA Network Open on the economics of telemedicine "house calls". Alongside my research, I founded and lead Research Roundtable, a mentorship group whose undergraduates have published 10+ first-author papers. Before medicine, with Peggy Mason at UChicago, I found the human bystander effect in rats (Science Advances). -
Chris Hayward
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)
Current Research and Scholarly InterestsDr. Hayward's research has focused on risk factors for the onset of adolescent internalizing disorders in adolescent girls and the role of early puberty specifically.
-
Alesha Heath
Basic Life Res Scientist, Psych/Public Mental Health & Population Sciences
BioDr. Alesha Heath is a Postdoctoral Scholar at Psychiatry and Behavioral Sciences at Stanford School of Medicine and the MIRECC the VA Palo Alto. She earned her PhD from the University of Western Australia and Sorbonne University.
Dr. Heath's research has been primarily focused on the mechanisms and applications of brain stimulation therapies, in particular repetitive transcranial magnetic stimulation. Her research involves both basic and clinical components with the aim of improving the efficacy of these therapies for the treatment of disorders such as depression and Alzheimer's disease.
